STOCK TITAN

Imunon, Inc. (IMNN) CEO awarded 5,010-share stock grant as compensation

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. President and CEO Stacy Lindborg reported a Form 4 showing a grant of 5,010 shares of Common Stock on July 31, 2026 at $1.59 per share, described as stock granted in lieu of cash for a portion of base salary. Following this award, she holds 86,639 shares directly and 778 shares indirectly through a 401(k) plan.

Positive

  • None.

Negative

  • None.
Insider Lindborg Stacy
Role President and CEO
Type Security Shares Price Value
Grant/Award Common Stock F1 5,010 $1.59 $8K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 86,639 shares (Direct); Common Stock — 778 shares (Indirect, By 401(k) Plan)
Footnotes (1)
  1. F1. Stock granted in lieu of cash for portion of base salary
Shares granted 5,010 shares of Common Stock Grant on July 31, 2026 as stock in lieu of cash for portion of base salary
Grant price $1.59 per share Valuation used for the 5,010-share stock grant to the CEO
Direct holdings after grant 86,639 shares Total Common Stock held directly by Stacy Lindborg following the reported grant
Indirect 401(k) holdings 778 shares Common Stock held indirectly by Stacy Lindborg through a 401(k) Plan
Grant, award, or other acquisition regulatory
"transaction_code_description: Grant, award, or other acquisition"
401(k) Plan financial
"nature_of_ownership: By 401(k) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
stock granted in lieu of cash for portion of base salary financial
"Footnote F1: Stock granted in lieu of cash for portion of base salary"
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Imunon (IMNN) report for its CEO?

Imunon CEO Stacy Lindborg reported a grant of 5,010 shares of Common Stock on July 31, 2026. The shares were awarded as stock in lieu of cash for a portion of her base salary, rather than a market purchase.

At what price were the 5,010 Imunon (IMNN) shares granted to the CEO?

The 5,010 Imunon shares were valued at a grant price of $1.59 per share. This reflects the price used for the stock granted in lieu of cash compensation for part of Stacy Lindborg’s base salary on July 31, 2026.

How many Imunon (IMNN) shares does CEO Stacy Lindborg own after this Form 4?

After the reported grant, Stacy Lindborg holds 86,639 Imunon common shares directly. She also has an additional 778 shares held indirectly through a 401(k) plan, as disclosed in the Form 4 filing’s ownership table.

Was the Imunon (IMNN) CEO stock grant made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as a 10b5-1 plan. The Form 4 indicates the transaction as a grant of stock in lieu of cash salary, without identifying it as executed under a pre-arranged trading plan.

What indirect Imunon (IMNN) holdings does the CEO report?

Stacy Lindborg reports 778 Imunon common shares held indirectly via a 401(k) Plan. This is in addition to her directly held 86,639 shares, and is shown as a separate indirect ownership entry in the Form 4 data.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lindborg Stacy

(Last)(First)(Middle)
C/O IMUNON, INC.
997 LENOX DRIVE, SUITE 100

(Street)
LAWRENCEVILLE NEW JERSEY 08648

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026A5,010(1)A$1.5986,639D
Common Stock778IBy 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Stock granted in lieu of cash for portion of base salary
/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)